Biomarin's most-sold drugs are accessible with insurance coverage, yet expensive in general
Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. Half of the global population avoids medical care because of the out-of-pocket cost2. The annual average income in the US as of 2024 is USD69,7173.
BioMarin Pharmaceu...
Register to read the full analysis —or— Upgrade to access more features
#cost
#price
#pricing
#returns
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.